Jace Jianxin Huang is the Senior Director of Oncology Early Commercial & Portfolio Strategy at GSK, with deep expertise in leading global product launches across the U. S. , Europe, and China. He holds dual MBAs from HEC Paris and Georgetown University and is certified in European Pharma Market Access.
He has a strong interest in technologys role in healthcare, particularly the application of AI in diagnosing rare cancers and diseases. He is also passionate about improving patient access to medication and has voiced concerns about drug affordability.
At his previous role at Ipsen, he led the commercial assessment for the license-in of Elafibrarnor, which was the companys largest transaction.
Read the full overview →Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.
Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.
Explore more public profiles from related professionals.
Discover additional public profiles from our index.
Looking for someone else? Search here for anyone.